A Year in Review
Monash IVF Group places great importance on partnering with doctors committed to delivering market-leading success rates & best-in-class patient experience.
Bali clinic
opened
15.9.2022
Total domestic
stimulated cycles
↑ 5.5%
On FY22 (FY23; 10,323)
New patient
stimulated cycles
↑ 7.2%
On FY22 (FY23; 5,251)
Domestic
acquisitions
2
Total Medical
Specialists
↑ 44%
On FY18 (FY23, 153)
New Patient
Registrations increased by
↑ 12%
Compared to FY22
Success rates
increased by
↑ 6.1%4
Since 2019
Employee Engagement
Culture of Success
+ 64%
Average patient
NPS score
+ 71%
On par with FY2023
In FY23, 25 new fertility specialists joined us through recruitment and business acquisition.
Revenue
$213.6m
↑ 11.1% on FY22
Underlying NPAT1,3
$25.5m
↑ 14.7% on FY22
Underlying EBITDA1,2
$53.4m
↑ 11.0% on FY22
Underlying EBIT1,2
$38.1m
↑ 14.2% on FY22
Reported NPAT3
$22.0m
↑ 18.9% on FY22
Reported EBITDA1
$48.5m
1. Non-IFRS measure
2. Refer to reconciliation of Reported EBITDA, EBIT and NPAT to Adjusted EBITDA, EBIT and NPAT
3. NPAT including minority interest
4. 2023 Jan-Mar